Prednisone Recruiting Phase 1 / 2 Trials for B-cell Non-Hodgkin's Lymphomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT03671018A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma